Repaglinide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 912 publications

Drug-Drug Interaction Between Eugenol and Repaglinide in Type 2 Diabetes Mellitus and Its Potential Mechanism.

Drug-Drug Interaction Between Eugenol and Repaglinide in Type 2 Diabetes Mellitus and Its Potential Mechanism.

Journal: Journal of visualized experiments : JoVE

Published: August 10, 2026

Green Sensitive Derivative Emission Spectrofluorimetry for the Estimation of Repaglinide and Febuxostat Simultaneously in Dosage Forms and Spiked Human Plasma.

Green Sensitive Derivative Emission Spectrofluorimetry for the Estimation of Repaglinide and Febuxostat Simultaneously in Dosage Forms and Spiked Human Plasma.

Journal: Luminescence : the journal of biological and chemical luminescence

Published: June 02, 2026

Predicting pH-Dependent Solubility Enhancement and Precipitation Suppression in Drug-Cyclodextrin-Arginine Formulations.

Predicting pH-Dependent Solubility Enhancement and Precipitation Suppression in Drug-Cyclodextrin-Arginine Formulations.

Journal: Pharmaceutics

Published: May 28, 2026

Ultrafast affinity extraction with non-covalent entrapment for biointeraction analysis: development and applications to single- and multi-site drug-protein binding.

Ultrafast affinity extraction with non-covalent entrapment for biointeraction analysis: development and applications to single- and multi-site drug-protein binding.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: May 13, 2026

The Impact of Polymers in Amorphous Solid Dispersion on the Bioavailability of Sulfonylureas and Meglitinides.

The Impact of Polymers in Amorphous Solid Dispersion on the Bioavailability of Sulfonylureas and Meglitinides.

Journal: Drug design, development and therapy

Published: March 19, 2026

Helicobacter pylori Eradication Therapy-induced Severe Hypoglycemia in a Hemodialysis Patient with Type 2 Diabetes Mellitus.

Helicobacter pylori Eradication Therapy-induced Severe Hypoglycemia in a Hemodialysis Patient with Type 2 Diabetes Mellitus.

Journal: Internal medicine (Tokyo, Japan)

Published: March 11, 2026

Repaglinide Provokes Dose-Dependent Myocardial Toxicity via Disrupting HIF-1α, TLR4/MyD88, and NF-κB Pathway: A Biochemical, Radiological, and Histological Approach.

Repaglinide Provokes Dose-Dependent Myocardial Toxicity via Disrupting HIF-1α, TLR4/MyD88, and NF-κB Pathway: A Biochemical, Radiological, and Histological Approach.

Journal: Journal of applied toxicology : JAT

Published: March 01, 2026

Actions of Midostaurin as Cation Channel and Tyrosine Kinase Inhibitor in Diffuse Intrinsic Pontine Glioma Cell Lines.

Actions of Midostaurin as Cation Channel and Tyrosine Kinase Inhibitor in Diffuse Intrinsic Pontine Glioma Cell Lines.

Journal: Cancers

Published: February 13, 2026

Investigation of Thymoquinone as an Inhibitor of CYP2C8/EET Axis.

Investigation of Thymoquinone as an Inhibitor of CYP2C8/EET Axis.

Journal: Chembiochem : a European journal of chemical biology

Published: January 13, 2026

Pharmacokinetic and Bioequivalence Evaluation of Two Repaglinide Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.

Pharmacokinetic and Bioequivalence Evaluation of Two Repaglinide Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.

Journal: Clinical pharmacology in drug development

Published: January 06, 2026

Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential.

Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential.

Journal: Clinical and translational science

Published: December 19, 2025

Using physiologically based pharmacokinetic modelling to optimize repaglinide and irbesartan dosing in Chinese population with SLCO1B1 polymorphism.

Using physiologically based pharmacokinetic modelling to optimize repaglinide and irbesartan dosing in Chinese population with SLCO1B1 polymorphism.

Journal: British journal of clinical pharmacology

Published: December 05, 2025

Showing 1-12 of 912

Last Updated: 09/26/2026